EUVIMEDEUVIMED entdecken
Crossref

Prognostic, Not Predictive: Reconsidering the “Immunotherapy-Resistant” Label in Infiltrative Hepatocellular Carcinoma

Haitao Zhang, Lei Wang, Xiaofeng Luan, Hangyu Liu

Clinical and Molecular Hepatology · 06.11.2026

DOI: 10.3350/cmh.2026.1165 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Molecular Hepatology, online erschienen am 06.11.2026. Verfasst von Haitao Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Central Hospital of Dalian University of Technology (Dalian Municipal Central Hospital).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Central Hospital of Dalian University of Technology (Dalian Municipal Central Hospital).
  • Central Hospital of Dalian University of Technology (Dalian Municipal Central Hospital). luanxiaofeng2000@sina.com.
  • Central Hospital of Dalian University of Technology (Dalian Municipal Central Hospital). 15382267266@163.com.

Zitieren

APA

Zhang, H., Wang, L., Luan, X., & Liu, H. (2026). Prognostic, Not Predictive: Reconsidering the “Immunotherapy-Resistant” Label in Infiltrative Hepatocellular Carcinoma. Clinical and Molecular Hepatology. https://doi.org/10.3350/cmh.2026.1165

Vancouver

Zhang H, Wang L, Luan X, Liu H. Prognostic, Not Predictive: Reconsidering the “Immunotherapy-Resistant” Label in Infiltrative Hepatocellular Carcinoma. Clinical and Molecular Hepatology. 2026. doi:10.3350/cmh.2026.1165

BibTeX
@article{Zhang2026,
  author = {Zhang, Haitao and Wang, Lei and Luan, Xiaofeng and Liu, Hangyu},
  title = {Prognostic, Not Predictive: Reconsidering the “Immunotherapy-Resistant” Label in Infiltrative Hepatocellular Carcinoma},
  journal = {Clinical and Molecular Hepatology},
  year = {2026},
  doi = {10.3350/cmh.2026.1165}
}
Kostenlos starten →